ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 165 filers reported holding ARIAD PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $820,000 | +32.3% | 65,954 | +42.1% | 0.00% | 0.0% |
| Q3 2016 | $620,000 | +75.1% | 46,419 | -3.6% | 0.00% | – |
| Q2 2016 | $354,000 | +41.0% | 48,134 | +22.5% | 0.00% | – |
| Q1 2016 | $251,000 | -1.2% | 39,309 | -2.5% | 0.00% | – |
| Q4 2015 | $254,000 | +21.0% | 40,302 | +12.4% | 0.00% | – |
| Q3 2015 | $210,000 | -28.3% | 35,858 | 0.0% | 0.00% | – |
| Q2 2015 | $293,000 | +8.9% | 35,858 | +12.5% | 0.00% | – |
| Q1 2015 | $269,000 | +52.8% | 31,881 | +24.8% | 0.00% | – |
| Q4 2014 | $176,000 | +18.1% | 25,540 | -3.2% | 0.00% | – |
| Q3 2014 | $149,000 | – | 26,388 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $94,961,000 | 26.95% |
| Consonance Capital Management LP | 8,845,742 | $65,370,000 | 9.25% |
| Opaleye Management Inc. | 1,250,000 | $9,238,000 | 6.17% |
| Tamarack Advisers, LP | 2,100,000 | $15,519,000 | 5.95% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 293,352 | $2,168,000 | 1.62% |
| Camber Capital Management LP | 4,000,000 | $29,560,000 | 1.43% |
| Palo Alto Investors LP | 2,535,117 | $18,735,000 | 1.42% |
| Granite Point Capital Management, L.P. | 430,890 | $3,184,000 | 1.37% |
| 1492 Capital Management LLC | 202,500 | $1,496,000 | 1.34% |
| HighVista Strategies LLC | 869,100 | $6,423,000 | 1.23% |